Call it the "Great Flattening"

Summary

Marketplace Morning Report: "Call it the 'Great Flattening'"

Date: May 21, 2026
Host: Sabri Benishore
Duration: ~10 minutes

---

Episode Overview

This episode highlights emerging trends in the tech industry, centering on the concept of "flatness"—a buzzword describing both corporate restructuring and advances in automation and artificial intelligence. It covers the latest in AI chip competition, widespread layoffs at major tech firms in pursuit of leaner organizations, the use and limits of AI in management, and a feature on the growing market—and scientific progress—of targeted alpha therapy for cancer treatment.

---

Key Discussion Points & Insights

1. Nvidia’s Financial Performance and AI Chip Competition

Segment: [00:46–01:52]

• Summary:

  • Nvidia, now the world’s most valuable company, reported it nearly doubled its revenue from AI data center systems, reaching $75 billion in the first quarter.
  • However, growth is slowing compared to prior years.
  • Nvidia is looking to diversify its customer base beyond hyperscale tech companies to include governments and robotics/autonomous vehicle manufacturers.
  • Major customers like Google, Amazon, Microsoft, and Meta are now designing their own AI chips, intensifying competition.

• Quote (Henry Epp, Marketplace):

  • “Nvidia nearly doubled its revenue from selling the computing systems that power AI data centers in the past year, topping $75 billion in the first quarter. But that growth is not as strong as it was a few years ago ... Google, Amazon, Microsoft, and Meta are all developing their own chips for AI.” [01:13]

---

2. The "Great Flattening": Tech Layoffs and the New Corporate Structure

Segment: [01:52–03:50]

• Summary:

  • Meta laid off about 8,000 employees aiming for a "flatter structure that can move faster."
  • The term "flatness" is now common in tech layoff announcements, signaling a reduction in management layers.
  • Middle managers have traditionally helped coordinate across growing organizations, but AI tools are increasingly performing their roles (e.g., consolidating status updates).
  • Experts warn of limits: Removing managers could overload remaining staff, and sprawling teams might hurt morale and efficiency.
  • Employee engagement has dropped to its lowest level in a decade; strong manager relationships are linked to better engagement.

• Memorable Quotes:

  • Tristan Botelho (Yale):
    “The classic job is getting 12 different status updates from four different departments and trying to understand it in one summary, which is something AI can do pretty well.” [02:25]
  • Megan McCarty Carino (Marketplace, reporter):
    “Large teams of 25 or more have become more common as companies collapse their org charts.” [03:00]
  • Jim Harder (Gallup):
    “If they treat it more as a transaction than as kind of a transformational way to upgrade the way that they manage people, then it can fail.” [03:16]
  • Megan McCarty Carino:
    “Employee engagement has dropped to a ten year low and manager relationships have a lot to do with that.” [03:25]

---

3. Targeted Alpha Therapy: A New Frontier in Cancer Treatment

Segment: [05:38–08:43]

• Summary:

  • Radiation has been used in cancer treatment for 125 years; the global market for radioactive drugs is expected to quadruple from $14 billion to $56 billion by 2034.
  • Typical treatments include external beam radiation or radioactive isotopes injected into the body.
  • The innovation: Targeted alpha therapy attaches radioactive isotopes (which emit powerful alpha particles) to molecules designed to seek out cancer cells, delivering a concentrated and localized hit while sparing healthy tissue.
  • Alpha particles are akin to “tanks”—short range but highly destructive in a confined area.
  • Beta radiation therapies are already in use (e.g., Lutathera, Pluvicto for gastrointestinal and prostate cancers), while alpha-targeting therapies are in late-stage clinical trials, notably those using Actinium-225.

• Memorable Quotes:

  • Mark Peplow (science journalist):
    “Alpha particles travel a much shorter distance, but they pack a much bigger punch ... The idea is to try and focus all of their energy on just the very small area of cancer cells that need to be eradicated.” [07:18]
  • Mark Peplow on treatment outlook:
    “Clinical trials are underway to find out ... For Actinium 225, that’s the most advanced, really. And we have some agents that progressed into the final stage of clinical testing. But, you know, there’s still a long way to go.” [07:58]

---

Notable Quotes (with Timestamps)

• “Meta ... wants to operate with a flatter structure that can move faster. That term flat or flatness has become a common refrain when tech companies cut jobs.”
  — Sabri Benishore, host [01:52]
• “Any executive can say, give me a status update from what you’re seeing at the team level. 2:00am 4:00am 7:00am 2:00pm it doesn’t matter.”
  — Sabri Benishore [02:35]
• “If you have more layers of responsibility and more levels of sign off than really allow you to be effective ... it could make sense to reduce that.”
  — Emily Rose McCrae (Gartner), [02:54]

---

Timestamps for Key Segments

• Nvidia results and AI chip competition: [00:46–01:52]
• Meta layoffs & “flatness” in tech: [01:52–03:50]
• AI and the changing role of managers: [02:16–03:25]
• Targeted alpha therapy for cancer: [05:38–08:43]

---

Tone and Style

Factual, brisk, and engaging, the episode reflects the Marketplace style—accessible with a business-savvy lens. Quotes are concise, and the presentation balances technical detail with broad context.

---

Summary Takeaways

• "Flatness" is reshaping tech, affecting both organizational charts and the kinds of roles AI takes on—middle managers especially.
• Nvidia’s stunning financial results underscore both the momentum and intensifying competition in AI hardware.
• There’s innovation and growth not just in tech, but also in biotech, as targeted alpha therapy promises a breakthrough in cancer treatment (pending clinical trials).
• Beneath the headlines, the human cost and complexity of these shifts—especially in workforce morale and engagement—remain pressing concerns.

---

This episode captures a moment of transition: technology is "flattening" organizations and tasks, but the impacts—both positive and challenging—are still unfolding.

Transcript

[A]

You're great at protecting your data, but lots of places could still expose you to identity theft.

[B]

I thought it was safe.

[A]

If that happens, LifeLock gives you a US based restoration agent who will stick by your side from start to finish. Phone calls, filing documentation, preparing insurance claims. Your agent handles it all. In fact, we're so confident restoration is guaranteed or your money back. Isn't it nice to have someone like that on your side? Save up to 30% your first [e-mail] specialoffer terms apply.

[C]

There's a fire inside you you can't ignore. Stand still. Not a chance. You're a lifelong learner who's come this far. Now we are here to help you keep going further. Capella University what can't you do? Visit capella.edu to learn more.

[D]

The latest buzzword in tech is flatness, and if you hear it run from Marketplace, I'm Sabri Benishore in New York. First chip making giant Nvidia, the world's most valuable company, reported financial results yesterday. It beat Wall Street's already high expectations, but the company is also facing stiffer competition. Marketplaces Henry Epp reports Nvidia nearly doubled

[E]

its revenue from selling the computing systems that power AI data centers in the past year, topping $75 billion in the first quarter. But that growth is not as strong as it was a few years ago, so the company also stressed to investors that it will div its customer base beyond the so called hyperscalers driving the AI boom. It wants to sell more to governments and to companies that make robots and autonomous vehicles. That says the company faces more competition in the market for AI chips, including from some of the huge tech firms that have been its biggest customers. Google, Amazon, Microsoft and Meta are all developing their own chips for AI. I'm Henry Epp for Marketplace.

[D]

About 8,000 employees of Meta lost their jobs this week. The company's looking to offset its massive spending on AI and, according to an internal memo quote, operate with a flatter structure that can move faster. That term flat or flatness has become a common refrain when tech companies cut jobs. Marketplaces Megan McCarty Carino has more it's

[B]

hard to coordinate between all the different parts of a growing company. That's where middle managers come in, says Tristan Botello at Yale School of Management.

[D]

The classic job is getting 12 different status updates from four different departments and trying to understand it in one summary,

[B]

which is something AI can do pretty well.

[D]

Any executive can say, give me a status update from what you're seeing at the team level. 2:00am 4:00am 7:00am 2:00pm it doesn't matter.

[B]

Tech companies are eager to cut expenses and red tape, says Emily Rose McCrae at Gartner. If you have more layers of responsibility and more levels of sign off than

[C]

really allow you to be effective, if

[B]

that's one of the major barriers, it

[C]

could make sense to reduce that.

[B]

But she says there are limits to how well AI can replicate. Human managers and companies could be overloading those who remain. Large teams of 25 or more have become more common as companies collapse their org charts, says Jim Harder at Gallup.

[F]

If they treat it more as a transaction than as kind of a transformational way to upgrade the way that they manage people, then it can fail, he says.

[B]

Employee engagement has dropped to a 10 year low and manager relationships have a lot to do with that. I'm Megan McCarty Carino for Marketplace.

[G]

Dell PCs with Intel inside are built for the moments that matter. For the moments you plan and the ones you don't. Built for the busy days that turn into all night study sessions. The moment you're working from a cafe and realize every outlet's taken the times you're deep in your flow and the absolute last thing you need is an auto update throwing off your momentum. That's why Dell builds tech that adapts to the way you actually work, built with long lasting battery so you're not scrambling for the closest outlet and built in intelligence that makes updates around your schedule, not in the middle of it. They don't build tech for tech's sake, they build it for you. Find technology built for the way you [e-mail] DellPCS built for you

[H]

the Marketplace Morning Report podcast is supported by three Day Blinds. We shop for everything at home now. Why can't we shop for blinds at home too? We can now with three day Blinds. Instead of wandering around a store, three Day Blinds sends a professional design consultant straight to you. They bring all the samples, help you see what actually works in your space, take expert measurements, and even handle the installation. We've all bought something that looked great in store and terrible once we got it home. With three day Blinds you see everything in your actual light with your actual furniture before you commit. Plus, whether you're at home or away, you can control your window treatments with the three day Blinds app. So for a free no charge and no obligation consultation, head to threedayblinds.com morning for our buy one get one 50% off deal. That's the number three D A Y blinds.com morning

[D]

radiation and radioactive materials have been Used to treat cancer for around 125 years. And these days, that includes injecting radioactive drugs into the body. That market is now worth almost $14 billion, and it's expected to grow to 56 billion by 2034. Progress in this field has been all about how to get the radiation to the cancer cells and avoid or minimize damage to healthy cells. There is a new type of therapy driving the growth in this industry that takes that progress a step further. It's called targeted alpha therapy. And Mark peplo has written about it for new scientists. He joins us. Hi, mark.

[F]

Hi.

[D]

The radiation treatment that most people are probably familiar with is where a doctor zaps a tumor, you know, with a beam of radiation. There's also injecting radioactive isotopes into a patient. This new way of using radiation is different. How?

[F]

It's different because often when patients receive radiotherapy, it will affect not just the cancer cells, but it will affect other parts of their body as well. Targeted alpha therapy, the idea of it is that you take a radioactive isotope that emits radiation and you attach it to a wrapper, a molecule that will seek out cancer cells so that it can deliver a targeted blast of radiation. The idea is that it makes the therapy much more effective and it reduces those off target side effects as well.

[D]

The radiation that's emitted by these isotopes in particular is kind of different. How so?

[F]

Yeah, so in high school, we learned that there are three different types of radiation. The first is called alpha. That's what we're talking about here. That is two protons and two neutrons. That makes up the nucleus of a helium atom, actually. And you can imagine these as slow, lumbering, very heavy, but they're like a tank. Right. They have huge amounts of energy. So alpha particles travel a much shorter distance, but they pack a much bigger punch. And the idea is to try and focus all of their energy on just the very small area of cancer cells that need to be eradicated.

[D]

How effective are they, these new treatments?

[F]

Clinical trials are underway to find out. Beta therapies. There are two sort of big successes over the last 10 years. One is called lutathera, One is called plavicto. And clinical trials have shown them to be very effective against gastrointestinal cancer and prostate cancer, respectively. As far as the alpha therapies go, the clinical trials are underway. Really? And different isotopes have reached different stages for Actinium 225. That's the most advanced, really. And we have some agents that progressed into the final stage of clinical testing. But, you know, there's still a long way to go.

[D]

Mark Peplo is a science journalist and former chief news editor at Nature. Thank you, Mark, so much.

[F]

Thank you.

[D]

From apm, American Public Media.

[G]

There's so much happening in the world, and if you have particularly, shall we say, inquisitive kids, and it can be hard to answer their questions. Hi, I'm Ryan.

[C]

And I'm Bridget. And we host Million Bazillion, a podcast from Marketplace about money for kids and their families. We help your little ones think big about important but tricky topics like taxes, gas prices, and even what a cashless society might be like.

[G]

There's a bunch of new episodes out now, so go listen to Million Bazillion on your favorite podcast app.